The aggressive character of gliomas and their resistance for currently available treatment resulted from overexpression of the intracellular survival pathways: PI3K-Akt/PKB-mTOR and Ras-Raf-MEK-ERK. This evidence concerns the gene AKT1 and central nervous system cancer.